The Supreme Court is set to rule on various crucial patent law cases, potentially impacting obviousness standards and PTAB procedures.
A recent Federal Circuit ruling impacts Cytonome’s microfluidic device patent, challenging the definition of "the sample stream" and its implications on patent validity.
